Standout Papers

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through ... 2023 2026 2024191
  1. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer (2023)
    Weihao Li, Chi Zhou et al. Autophagy

Immediate Impact

23 standout
Sub-graph 1 of 11

Citing Papers

H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
1 intermediate paper

Works of Lan Jin being referenced

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
2023 Standout
Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway
2019

Author Peers

Author Last Decade Papers Cites
Lan Jin 209 13 40 109 41 11 329
Yong Du 194 4 28 120 63 14 371
Andréia Barroso 133 4 32 35 64 7 360
Nan Yi 188 9 46 56 40 17 354
Weixin Yan 160 7 22 92 35 15 363
Jia Liu 214 17 30 38 29 13 327
Ai-Li Xu 176 10 10 119 18 12 357
Guilin Wang 164 8 33 56 21 13 337
Chiara Suvieri 134 3 33 72 102 18 325
Reza Yari 204 16 21 168 26 19 355
Luling He 162 13 20 63 22 17 328

All Works

Loading papers...

Rankless by CCL
2026